New Delhi (PTI): The Supreme Court on Tuesday granted bail to BRS leader K Kavitha in the corruption and money laundering cases linked to the alleged Delhi excise policy scam.

A bench of Justices B R Gavai and K V Viswanathan noted that Kavitha has been in custody for around five months and the probe against her by the Central Bureau of Investigation (CBI) and the Enforcement Directorate (ED) was complete in these cases.

The apex court set aside a July 1 Delhi High Court order denying her bail.

The high court had dismissed Kavitha's bail pleas in both cases, saying she was prima facie one of the main conspirators in the criminal conspiracy related to the formulation and implementation of the now-scrapped Delhi Excise Policy 2021-22.

The ED arrested Kavitha (46) from her Banjara Hills residence in Hyderabad on March 15. The CBI arrested her on April 11 from Tihar jail.

Kavitha has denied all allegations.

 

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Bengaluru: In response to the deaths of postnatal women at Ballari District Hospital, the Karnataka government has temporarily suspended the use of IV Ringer Lactate solution across the state as a precautionary measure, Health Minister Dinesh Gundu Rao announced on Saturday.

Speaking to the media in Bengaluru, the minister explained that doubts about the quality of the IV solution had arisen, prompting the decision. He clarified that Ringer Lactate, along with glucose solutions, has been routinely used in hospitals for years. However, out of the 192 batches supplied by the Karnataka State Drugs Logistics and Warehousing Society, concerns were raised regarding two specific batches.

"In light of these concerns, we stopped the use of all 192 batches as a precaution. Following this, the supplying company obtained a High Court order for testing, and the Central Drugs Laboratory (CDL) conducted an analysis. The CDL report confirmed the usability of the solution, allowing the state to form a technical committee to review and permit the use of certain batches that met quality standards. Despite this, doubts have surfaced specifically at Ballari District Hospital," the minister stated.

To address these concerns, the batches supplied to Ballari Hospital have been sent for anaerobic testing to determine whether the IV solution contributed to the deaths. The test results are expected within a week, after which a final decision on the use of IV Ringer Lactate will be made.

"Until then, we have issued directives to hospitals statewide to suspend the use of IV Ringer Lactate. Every life is important to us, and precautionary measures are essential when suspicions arise," Gundu Rao emphasised.